Projects (125)

Vacation studentship  (27/06/2011  -  26/08/2011)

Vaccines manufacturing hub for LMIC Vax-Hub-Global  (01/09/2023  -  29/02/2028)

Validate ESMCP report  (03/07/2015  -  16/07/2015)

Validating and explaining the presenting skills assessment for medics  (01/07/2014  -  15/12/2018)

Validating exosomes as a novel therapeutic strategy using established models of Hepatocellular Carcinoma  (01/07/2018  -  15/04/2023)

Validating methylation sensing proteins as therapeutic targets  (01/07/2008  -  30/06/2013)

Validating prognostic biomarkers for colorectal cancer and determining their clinical utility  (01/11/2018  -  30/06/2025)

Validating the use of piezoelectric materials for novel application in bio-mechanical engineering  (01/04/2013  -  29/04/2014)

Validation and Development of Markers for Sheep Maternal Ability  (01/03/2023  -  31/05/2024)

Validation and examination of NGS Fragmentation reaction sizes using agilent tapestation  (01/03/2018  -  31/03/2019)

Validation and use of a model system to investigate topical treatment of vulval intraepithelial neoplasia  (01/01/2010  -  15/01/2013)

Validation in rodent models of a novel approach to treat mood disorders based on ERK signalling stimulation  (01/10/2016  -  30/09/2018)

Validation of a new AI solution to predict relapse at 5-10 years on histology slides in early breast cancer patients  (01/03/2024  -  28/02/2026)

Validation of an improved synthesis of 18F-Flumazenil  (01/08/2020  -  31/10/2021)

Validation of a novel adapted qSOFA score to predict death in Malawian children with suspected infection  (01/06/2020  -  31/07/2020)

Validation of a stem cell derived cartilage model for osteoarthritis research and drug screening  (21/12/2020  -  31/01/2022)

Validation of LIMK1 as a novel target in the treatment of breast cancer  (01/09/2021  -  28/02/2022)

Validation of nWASP (neural Wiskott-Aldrich Syndrome Protein) as a therapeutic target in chronic non-healing human wounds  (01/01/2014  -  31/12/2016)

Validation of nWASP (Neuronal Wiskott-Aldrich Syndrome Protein) as a therapeutic target in chronic and non-healing human wounds  (01/01/2014  -  30/06/2017)

Validation of pharmatracer for fdg production  (01/08/2013  -  31/07/2014)

Validation of Ras-ERK inhibitors to treat L-DOPA induce Dyskinesia  (01/01/2013  -  01/11/2014)

Validation of the findings that HPV methylation predicts response to treatment of VIN with imiquimod and cidofovir  (01/09/2019  -  31/12/2019)

Validation of the Mycoplasma IST3 performance  (04/02/2019  -  31/07/2019)

Validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors: Optimising the design of a subsequent randomised discontinuation trial: VALTIVE1  (01/01/2020  -  30/09/2024)

Valleys learning portfolio  (01/01/2011  -  30/06/2011)